Abstract
Abstract
Background
End-stage and acquired cystic renal disease (ESRD/ACRD) kidneys are characterized by inflammatory remodelling and multiplex renal cell carcinomas (RCC). Eosinophilic vacuolated tumour (EVT) occurs exclusively in ACRD. The aim of this study was to identify the involvement of thioredoxin-interacting protein (TXNIP) and thioredoxin (TXN) in ESRD/ACRD pathology.
Methods
Expression of TXNIP and TXN was examined in histological slides of 6 ESRD and 6 ACRD kidneys, precursor lesions and associated tumours as well as of RCCs from the general population by immunohistochemistry.
Results
Strong TXNIP expression was seen in epithelial cells, myo-fibroblasts and endothelial cells and weak TXN expression in ESRD/ACRD kidneys and tumours. In ACRD specific EVT and its precursors TXN were translocated into nuclei.
Conclusion
The impaired TXNIP/TXN redox homeostasis might be associated with development of multiplex cancer especially of EVT in ESRD/ACRD kidney.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. U.S. Renal Data System. USRDS 2013. Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013.
2. Chaudhary K, Phadke G, Nistala R, Weidmeier CE, McFairlane SI, Whaley-Connell A. The emerging role of biomarkers in diabetic and hypertensive chronic kidney disease. Curr Diab Rep. 2010;10:37–42.
3. Hughson MD, Buchwald D, Fox M. Renal neoplasia and acquired cystic disease in patients receiving long-term dialysis. Arch Pathol Lab Med. 1986;110:592–601.
4. Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141–53.
5. Nagy A, Walter E, Zubakov D, Kovacs G. High risk of development of renal c ell tumor in end-stage kidney disease: the role of microenvironment. Tumor Biol. 2016;37:9511–9.